Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Morris

Showing results (201-210 of 324) with videos related to

Pageof 33
Sort By:
Scientific Reports|October 1, 2022
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanismsThandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 18, 2007
Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'IvoireNeil A Martinson, Didier K Ekouevi, Francois Dabis, et al.
AIDS (London, England)|February 3, 2016
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected womenNonhlanhla N Mkhize, Raveshni Durgiah, Vicki Ashley, et al.
Journal of Virology|February 14, 2006
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1Penny L Moore, Emma T Crooks, Lauren Porter, et al.
Plos One|July 7, 2015
Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal LavageDerseree Archary, Lenine J Liebenberg, Lise Werner, et al.
Plos Pathogens|November 17, 2021
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infectionDieter Mielke, Gama Bandawe, Jie Zheng, et al.
Virology|March 21, 2009
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccinationKatie L Davis, Elin S Gray, Penny L Moore, et al.
Antiviral Therapy|June 26, 2008
World Health Organization/HIVResNet Drug Resistance Laboratory StrategySilvia Bertagnolio, Inge Derdelinckx, Monica Parker, et al.
ESC Heart Failure|May 3, 2021
Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance databaseMelissa Y Y Moey, Rahim A Jiwani, Kotaro Takeda, et al.
Journal of Virological Methods|December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer designValerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
Pageof 33

Showing results (201-210 of 324) with videos related to

Sort By:
Pageof 33
Scientific Reports|October 1, 2022
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanismsThandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 18, 2007
Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'IvoireNeil A Martinson, Didier K Ekouevi, Francois Dabis, et al.
AIDS (London, England)|February 3, 2016
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected womenNonhlanhla N Mkhize, Raveshni Durgiah, Vicki Ashley, et al.
Journal of Virology|February 14, 2006
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1Penny L Moore, Emma T Crooks, Lauren Porter, et al.
Plos One|July 7, 2015
Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal LavageDerseree Archary, Lenine J Liebenberg, Lise Werner, et al.
Plos Pathogens|November 17, 2021
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infectionDieter Mielke, Gama Bandawe, Jie Zheng, et al.
Virology|March 21, 2009
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccinationKatie L Davis, Elin S Gray, Penny L Moore, et al.
Antiviral Therapy|June 26, 2008
World Health Organization/HIVResNet Drug Resistance Laboratory StrategySilvia Bertagnolio, Inge Derdelinckx, Monica Parker, et al.
ESC Heart Failure|May 3, 2021
Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance databaseMelissa Y Y Moey, Rahim A Jiwani, Kotaro Takeda, et al.
Journal of Virological Methods|December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer designValerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
Pageof 33